Case Report of Non-Small Cell Lung Cancer with STRN-ALK Translocation: A Nonresponder to Alectinib

被引：30
|
作者：
Nakanishi, Yoko [1 ]
Masuda, Shinobu [1 ]
Iida, Yuko [2 ]
Takahashi, Noriaki [2 ]
Hashimoto, Shu [2 ]
机构：
[1] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Oncol Pathol, Tokyo, Japan
[2] Nihon Univ, Sch Med, Dept Internal Med, Div Resp Med, 30-1 Ohyaguchi Kamimachi, Tokyo 1738610, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 12期
关键词：
POTENTIAL THERAPEUTIC TARGET; FUSION;
D O I：
10.1016/j.jtho.2017.08.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E202 / E204
页数：4
相关论文
共 50 条
  • [41] Bayesian analysis supports the role of alectinib and ensartinib for ALK-positive non-small cell lung cancer
    Rizzo, Alessandro
    THORACIC CANCER, 2023, 14 (13) : 1217 - 1217
  • [42] Economic impact of preventing brain metastases with alectinib in ALK-positive non-small cell lung cancer
    Burudpakdee, C.
    Wong, W.
    Seetasith, A.
    Corvino, F. A.
    Yeh, W.
    Gubens, M.
    LUNG CANCER, 2018, 119 : 103 - 111
  • [43] Erratum to: Alectinib: A Review of Its Use in Advanced ALK-Rearranged Non-Small Cell Lung Cancer
    Kate McKeage
    Drugs, 2015, 75 : 241 - 241
  • [44] The role of BIM gene deletion in ALK-mutated Non-small cell lung cancer treated with alectinib
    Hou, Shuang
    Zhang, Weijun
    Pang, Wei
    Xia, Haiqun
    Tan, Jinyun
    Huang, Qingfang
    Yang, Ping
    CLINICAL AND EXPERIMENTAL MEDICINE, 2025, 25 (01)
  • [45] Personalized medicine: paradigm shift in ALK positive non-small cell lung cancer: a case report
    Barreira, Joao Vasco
    Mendes, Jose Leao
    Parmanande, Anuraj
    JOURNAL OF MEDICAL CASE REPORTS, 2023, 17 (01)
  • [46] Lorlatinib experience in a patient with ALK plus non-small cell lung cancer on hemodialysis: A case report
    Gurbuz, Ali Fuat
    Eryilmaz, Melek Karakurt
    Yildiz, Oguzhan
    Kaya, Bahattin Engin
    Araz, Murat
    Artac, Mehmet
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2025, 31 (01) : 160 - 163
  • [47] Personalized medicine: paradigm shift in ALK positive non-small cell lung cancer: a case report
    João Vasco Barreira
    José Leão Mendes
    Anuraj Parmanande
    Journal of Medical Case Reports, 17
  • [48] Alectinib in resected ALK-positive non-small-cell lung cancer
    Gourmet, Anais
    Ferrari, Victoria
    BULLETIN DU CANCER, 2024, 111 (10) : 905 - 906
  • [49] Alectinib for advanced ALK-positive non-small-cell lung cancer
    Ly, Ashley C.
    Olin, Jacqueline L.
    Smith, Morgan B.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2018, 75 (08) : 515 - 522
  • [50] Alectinib in a patient with ALK-positive non-small lung cancer unable to swallow capsules
    Ishiura, Yoshihisa
    Nomura, Shosaku
    Ishii, Yuka
    Imai, Kai
    Nakahama, Kahori
    Sawai, Yusuke
    Tamaki, Takeshi
    Shimizu, Toshiki
    Miyashita, Naoyuki
    Ito, Tomoki
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (05) : 1283 - 1285
12345